← Eichor
Condition: Healthy Male Volunteers Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Healthy Male Volunteers

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Vasopressin and Pain Perception in the Brain
Phase 1/Phase 2 · 1 location(s) · University of Maryland, Baltimore · NCT03446456Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
NA · 1 location(s) · Scott Silveira · NCT07144527To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects
Phase 1 · 1 location(s) · Prestige Biopharma Limited · NCT05108259Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia
Phase 1/Phase 2 · 4 location(s) · Absci Pty Ltd. · NCT07317544Assessing the Impact of a Leucine Enriched Whey Protein vs Isonitrogenous Whey on Muscle Protein Synthetic Responses in
NA · 1 location(s) · University of Nottingham · NCT06971822Evaluating a Mat-Based Biometric Vibration System for Sleep and Daily Recovery
NA · 1 location(s) · Florida International University · NCT07221318Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers
Phase 1 · 1 location(s) · Joincare Pharmaceutical Group Industry Co., Ltd · NCT07207291Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT04354064A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and Tolerability of Bmab3000 and Hercep
Phase 1 · 1 location(s) · Biocon Biologics UK PLC · NCT07299955Ultralow Dose PET Imaging for PSMA Expression
Phase 2 · 1 location(s) · Akiva Mintz · NCT06904313Blood Flow Restriction (BFR) Training on the Ulnar Collateral Ligament (UCL)
NA · 1 location(s) · The Methodist Hospital Research Institute · NCT06664827Food Effect on PK of DW-1021 (Pelubiprofen 45 mg / Tramadol 45.9 mg) in Healthy Adults
Phase 1 · 2 location(s) · Haiphong University of Medicine and Pharmacy · NCT07060209Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions
Phase 1 · 2 location(s) · Haiphong University of Medicine and Pharmacy · NCT07032558A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Japanese Healthy People and Japanese People With
Phase 1 · 3 location(s) · Boehringer Ingelheim · NCT07693231A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fas
Phase 1 · 1 location(s) · Berlin-Chemie AG Menarini Group · NCT07201584Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019
Phase 1 · 1 location(s) · Grünenthal GmbH · NCT07479745Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepati
Phase 1 · 2 location(s) · Atea Pharmaceuticals, Inc. · NCT06911320A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
Phase 1/Phase 2 · 5 location(s) · Ingenia Therapeutics INC · NCT07231679Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fasting Conditions
Phase 1 · 1 location(s) · AJU Pharm Co., Ltd. · NCT07643220Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
NA · 2 location(s) · University of Alabama at Birmingham · NCT06989320A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®
Phase 1 · 1 location(s) · Berlin-Chemie AG Menarini Group · NCT07156916A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years
Phase 1 · 1 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT07413666Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol
Phase 1 · 1 location(s) · BioCorRx Pharmaceuticals Inc · NCT07269873A Study of ORN252 in Healthy Participants
Phase 1 · 1 location(s) · Orna Therapeutics, Inc. · NCT07439796A Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of [14C]-MRM-3379
Phase 1 · 1 location(s) · Mirum Pharmaceuticals, Inc. · NCT07712718Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT02379429A Phase 1 Study of CLYM116 in Normal Healthy Volunteers
Phase 1 · 1 location(s) · Climb Bio, Inc. · NCT07248865The Effects of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Anxiety Responses and Emotional Regulation
NA · 1 location(s) · University of Electronic Science and Technology of China · NCT07369908Near-InfraRed Spectroscopy of Auricular Stimulation
NA · 1 location(s) · University of Pittsburgh · NCT06825364Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt and Evaluation of Potential Drug-Drug Interactions
Phase 1 · 1 location(s) · Enyo Pharma · NCT07251153
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.